Liposome-mediated adenomatous polyposis coli gene therapy: A novel anti-adenoma strategy in multiple intestinal neoplasia mouse model

Diseases of the Colon and Rectum

Volumn 47, Issue 12, 2004, Pages 2105-2113

  Lee, Jack ^a   Hargest, Rachel ^b   Wasan, Harpreet ^c   Phillips, Robin K S ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b NEVILL HALL HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adenomatous polyposis coli; Familial adenomatous polyposis; Gene therapy; Liposomes

Indexed keywords

GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; LIPOSOME; PLASMID VECTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; GENE REPLACEMENT THERAPY; GENE THERAPY; HETEROZYGOSITY; INTESTINE TUMOR; MOUSE; NONHUMAN; REPORTER GENE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADENOMATOUS POLYPOSIS COLI; ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ENTERAL NUTRITION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, APC; GENES, REPORTER; GERM-LINE MUTATION; GREEN FLUORESCENT PROTEINS; HUMANS; INTESTINAL NEOPLASMS; LIPIDS; MICE; MICE, INBRED C57BL; PLASMIDS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 13144306089     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-0722-9     Document Type: Article

References (42)

1. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
2. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253:661-5.
3. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-9.
4. Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2: 783-5.
5. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998;85:742-50.
6. Vasen HF, Bulow S, Myrhoj T, et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 1997;40:716-9.
7. Lillemoe K, Imbembo AL. Malignant neoplasms of the duodenum. Surg Gynecol Obstet 1980;150:822-6.
8. Jones TR, Nance FC. Periampullary malignancy in Gardner's syndrome. Ann Surg 1977;185:565-73.
9. Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988;1:1149-51.
10. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, Mc-Gannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639-42.
11. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993;36: 1059-62.
12. Nugent KP, Spigelman AD, Williams CB, Talbot IC, Phillips RK. Surveillance of duodenal polyps in familial adenomatous polyposis: progress report. J R Soc Med 1994;87:704-6.
13. Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41.
14. Tsiotos GG, Sarr MG. Pancreas-preserving total duodenectomy. Dig Surg 1998;15:398-403.
15. Yeo CJ. Pylorus-preserving pancreaticoduodenectomy. Surg Oncol Clin N Am 1998;7:143-56.
16. Penna C, Phillips RK, Tiret E, Spigelman AD. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg 1993;80:1027-9.
17. de Vos tot Nederveen Cappel WH, Jarvinen HJ, Bjork J, Berk T, Griffioen G, Vasen HF. Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 2003;90:705-10.
18. Alarcon FJ, Burke CA, Church JM, van Stolk RU. Familial adenomatous polyposis: efficacy of endoscopic and surgical treatment for advanced duodenal adenomas. Dis Colon Rectum 1999;42:1533-6.
19. Mlkvy P, Messmann H, Debinski H, et al. Photodynamic therapy for polyps in familial adenomatous polyposis - a pilot study. Eur J Cancer 1995:31A:1160-5.
20. Kashiwagi H, Spigelman AD. Gastroduodenal lesions in familial adenomatous polyposis. Surg Today 2000;30: 675-82.
21. Spigelman AD, Talbot IC, Penna C, et al. Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol 1994;47:709-10.
22. Stolte M, Pscherer C. Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol 1996;31:376-82.
23. Fearnhead NS, Britton MP, Bodmer WF. The abc of apc. Hum Mol Genet 2001;10:721-33.
24. Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 1996;93:7950-4.
25. Hsi LC, An German-Stewart J, Eling TE. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis 1999;20:2045-9.
26. GTAC. Health Department of the United Kingdom Gene Therapy Advisory Committee. Guidance on making proposals to conduct gene therapy research on human subjects. Hum Gene Ther 2001;12:711-20.
27. Hargest R, Eldin A, Williamson R. Gene therapy for familial adenomatous polyposis. Prolonged expression of the adenomatous polyposis coli gene after lipofection into mouse colon in vivo. Adv Exp Med Biol 1998;451: 385-91.
28. Westbrook CA, Chmura SJ, Arenas RB, Kim SY, Otto G. Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Mol Genet 1994;3:2005-10.
29. Banerjee R. Liposomes: applications in medicine. J Biomater Appl 2001;16:3-21.
30. Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci 2001;6:66-77.
31. Hargest R, Williamson R. Expression of the APC gene after transfection into a colonic cancer cell line. Gut 1995;37:826-9.
32. Roy HK, Karolski WJ, Ratashak A. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int J Cancer 2001;92:609-15.
33. Hanson WR, Osborne JW. Epithelial cell kinetics in the small intestine of the rat 60 days after resection of 70 per cent of the ileum and jejunum. Gastroenterology 1971; 60:1087-97.
34. Yang K, Fan K, Kurihara N, et al. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. Carcinogenesis 2003;24:605-11.
35. Wasan HS, Park HS, Liu KC, et al. APC in the regulation of intestinal crypt fission. J Pathol 1998;185:246-55.
36. Lew JL, Guo Y, Kim RK, Vargish L, Michelassi F, Arenas RB. Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive. J Gastrointest Surg 2002;6:563-8.
37. Ritland SR, Gendler SJ. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. Carcinogenesis 1999;20:51-8.
38. Chiu CH, McEntee MF, Whelan J. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res 1997;57:4267-73.
39. Nabel EG, Gordon D, Yang ZY, et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gene Ther 1992;3: 649-56.
40. Bright-Thomas RM, Agrawal A, Hargest R. Preclinical studies of gene transfer for the treatment of desmoid disease in familial adenomatous polyposis. Br J Surg 2002;89:1563-9.
41. Caplen NJ, Alton EW, Middleton PG, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995;1:39-46.
42. Niedzinski EJ, Bennett MJ, Olson DC, Nantz MH. Gastroprotection of DNA with a synthetic cholic acid analog. Lipids 2000;35:721-7.